Targovax to present at upcoming investor and scientific conferences

 

OSLO, Norway, May 21, 2021 /PRNewswire/ -- Targovax ASA, today announces that members of its executive management team is invited to present at upcoming conferences.

ABGSC Life Science Summit, virtual

 

Date: 25 May 2021
Presenter: Øystein Soug (CEO)
Time: 16:30 CET

 

Oncolytic Viruses Virtual Symposium

 

Date: 25 May 2021
Presenter: Magnus Jäderberg (CMO)
Time: 10:45 CET

 

For further information, please contact:

 

Øystein Soug, CEO
Phone: +47 906 56 525
Email: oystein.soug@targovax.com

 

Renate Birkeli, Investor Relations
Phone: +47 922 61 624
Email: renate.birkeli@targovax.com

Media enquires:

 

Andreas Tinglum - Corporate Communications (Norway)
Phone: +47 9300 1773
Email: andreas.tinglum@corpcom.no

 

IR enquires:

 

Kim Sutton Golodetz - LHA Investor Relations (US)
Email: kgolodetz@lhai.com
Phone: +1 212-838-3777

 

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/targovax/r/targovax-to-present-at-upcoming-investor-and-scientific-conferences,c3351082

 

 

 

 

 

Cision View original content:http://www.prnewswire.com/news-releases/targovax-to-present-at-upcoming-investor-and-scientific-conferences-301296672.html

SOURCE Targovax

 
 
Company Codes: Bloomberg:TRVX@NO, ISIN:NO0010689326, Oslo:TRVX, RICS:TRVX.OL
 

Back to news